The college will take strong, proactive measures to reduce costs commensurate with an anticipated smaller incoming class for Fall 2019, and perhaps for the next several years.
Aloha UH Hilo ‘Ohana:
I write today to inform you of news concerning our Daniel K. Inouye College of Pharmacy (DKICP).
When the Daniel K. Inouye College of Pharmacy opened in 2007 there was a severe shortage of pharmacists in Hawai‘i and a shortage of capacity in pharmacy schools nationwide. DKICP was launched to address these gaps with an innovative financial plan that was based on a strong base of non-resident students who would complement local enrollment and pay a higher tuition rate.
While DKICP continues to serve a unique and vital mission for Hawai‘i and the Pacific, the rapidly changing healthcare environment in Hawai‘i, the Pacific, and the nation has negatively affected enrollment. As a result, DKICP will take strong, proactive measures to reduce costs commensurate with an anticipated smaller incoming class for Fall 2019, and perhaps for the next several years.
At the same time, DKICP will initiate a process of program redesign, consistent with ACPE accreditation, to help reverse the current enrollment decline by attracting more students. This will be complemented with an investment in aggressive, competitive recruitment initiatives, which will be enhanced with the availability of the new state-of-the-art DKICP education and research facility that opens Fall 2019 in our University Park of Science and Technology.
Painful as these measures are today, UH Hilo and DKICP share in the excitement of new opportunities so that we can continue to prepare our students to excel as they participate in and shape the dynamic and challenging field of pharmacy and healthcare in Hawai‘i and beyond.